E, A., S, Z., P, K., M, B., P, M., M, A., . . . MS, A. (2013). Nanolipodendrosome-loaded glatiramer acetate and myogenic differentiation 1 as augmentation therapeutic strategy approaches in muscular dystrophy. Dove Medical Press.
Chicago Style (17th ed.) CitationE, Afzal, et al. Nanolipodendrosome-loaded Glatiramer Acetate and Myogenic Differentiation 1 as Augmentation Therapeutic Strategy Approaches in Muscular Dystrophy. Dove Medical Press, 2013.
MLA (8th ed.) CitationE, Afzal, et al. Nanolipodendrosome-loaded Glatiramer Acetate and Myogenic Differentiation 1 as Augmentation Therapeutic Strategy Approaches in Muscular Dystrophy. Dove Medical Press, 2013.
Warning: These citations may not always be 100% accurate.